knowledge -WSS

knowledge

author：explore 2025-10-01 20:16:22 - browse：13457

Sammy Kimball for STAT

Can Novavax finally get it right? What’s a “triple-G” drug? And is Novo Nordisk losing ground?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Elaine Chen joins us to explain how the era of Wegovy could be short-lived in light of powerful new weight-loss medicines from Eli Lilly. Then, John Jacobs, the new CEO of Novavax, stops by to explain his plan to right the ship at a company that has struggled to make the most of its potent Covid-19 vaccine.

For more on what we cover, here’s the news on Lilly; here’s more on Novavax; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Class action alleges UnitedHealth concealed DOJ probe

focus

Wikipedia

focus

WSS

Most antidepressants don't work on kids, teens, study finds

PBM executives asked to testify by House panel

What happened to the House vote on health price transparency?

FDA panel to weigh safety of artificial wombs for preterm births

Has Bernie Sanders reached the limit of his pharma bullying effort?

How a small hospital in rural Puerto Rico survived Hurricane Maria

knowledge

knowledge

explore

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Warren pushes Witty on UnitedHealth's control over physicians

Continuity nursing helped my family in our darkest PICU moments

Why the quest to eradicate polio has stumbled

The high cost of giving birth even with insurance

Is it ever OK for doctors to lie to their patients?

Affirmative action in medical school literally saved lives

Senate bill would ban some hospital facility fees

23andMe had bad news about my health. I wish a person had delivered it

AltruBio raises $225 million to develop ulcerative colitis drug

focus

AltruBio raises $225 million to develop ulcerative colitis drug

Chemotherapy before breast cancer surgery might fuel metastasis

Free Covid tests will again be offered to all U.S. households

Primary care doctor shortage won't be solved by free med school tuition

'A game

PBMs drew scrutiny in House hearing — and so did pharma

focus

Wikipedia

focus

Wikipedia